Transplant News and Research

RSS

Enrollment suspended in WorldHeart's Levacor Ventricular Assist Device Bridge-To-Transplant Study

World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has paused enrollment in its Levacor Ventricular Assist Device (VAD) Bridge-To-Transplant (BTT) Study pending U.S. Food and Drug Administration (FDA) review and approval of the previously announced device refinements.

10 Feb 2011

IDF commends Illinois advisory committee for unanimous vote to recommend SCID Newborn Screening

The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.

9 Feb 2011

Rational use of heath care dollars for tonsillectomy

Without fanfare, hundreds of thousands of children surrender their tonsils to a surgeon's scalpel each year, usually to alleviate recurring infections and obstructive sleep problems. Most of the time, the snipped tonsils are sent to a pathologist, who looks for evidence of more serious medical problems, like unsuspected cancer.

9 Feb 2011

bcl3 gene limits lung injury during acute stress from illness, trauma, transplant

Lung injury is a common cause of death among patients with pneumonia, sepsis or trauma and in those who have had lung transplants. The damage often occurs suddenly and can cause life-threatening breathing problems and rapid lung failure.

9 Feb 2011

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

Gentium S.p.A. today announced that ongoing preclinical and clinical studies on Defibrotide have been completed and confirmed its plan to file for regulatory approval of Defibrotide with the US Food and Drug Administration and the European Medicines Agency by the end of the second quarter of 2011.

9 Feb 2011

RemedyMD announces new ComprehensiveBMT to solve key HSCT research challenges

RemedyMD has identified the need within the HSCT community to build software that can aggregate, link, harmonize, and analyze data from patients and donors and then report data as necessary to the CIBMTR.

8 Feb 2011

Study on non-surgical approach for treatment of liver hydatidosis

Concerning treatment, until recently the only definitive treatment for hydatid disease had been surgery. Different surgical techniques and procedures have been carried out and even in some cases, a liver transplant has been required. Advances in drug therapy has been influenced by the introduction of albendazole and accelerated by addition of praziquantel, but this requires a long period of treatment i.e. up to a year or more, and is not effective for everyone.

8 Feb 2011

XDx and LabCorp enter non-hospital provider agreement for AlloMap molecular expression tests

XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests to monitor immune-mediated conditions, today announced that it has entered into a multi-year agreement with Laboratory Corporation of America Holdings to provide heart transplant patients eligible for XDx's AlloMap® test with the convenience of having their blood drawn at participating LabCorp sites across the United States.

7 Feb 2011

Blood test for screening mad cow disease to come soon: Study

UK scientists have developed a new blood test that can diagnose cases of variant Creutzfeldt-Jakob Disease (vCJD), a rare, fatal brain disease caused by proteins known as prions. These prions are also responsible for the mad cow disease, or bovine spongiform encephalopathy (BSE). This test could in near future be used to identify contaminated blood and prevent transmission of the disease during blood transfusions, the researchers said.

6 Feb 2011

BCBSIL, IHA partner to reduce Illinois hospital readmissions through PREP initiative

Blue Cross and Blue Shield of Illinois and the Illinois Hospital Association are joining forces to reduce Illinois hospital readmissions through a new quality initiative—Preventing Readmissions through Effective Partnerships.

5 Feb 2011

Viewpoints: Judge Vinson's decision and Sarah Palin, Voting Rights Act; States' Medicaid 'burden;' Global fund controversy

With news coverage focused on Federal District Judge Roger Vinson's decision Monday to declare the health care reform law unconstitutional, it might be easy to miss this week's news from another federal courthouse: opponents of the Voting Rights Act have renewed their efforts to have that law declared unconstitutional, too.

5 Feb 2011

Engineered cells take control of the cells and microenvironment following transplantation

In work that could jumpstart the promising field of cell therapy, in which cells are transplanted into the body to treat a variety of diseases and tissue defects, researchers at Brigham and Women's Hospital (BWH) have engineered cells that could solve one of the key challenges associated with the procedure: control of the cells and their microenvironment following transplantation.

4 Feb 2011

Pediatric neurosurgery patient named Grand Marshal of 2011 Go the Distance fundraising event

A quiet, peaceful evening last summer quickly turned into a nightmare for parents Amanda and Bryan Tormey when they were awoken by sounds of their three year-old son, Nathan, stirring in his bed. When they checked on him, the cause of Nathan's restlessness became frighteningly evident; Nathan was in the midst of massive seizure that would ultimately incapacitate him for several hours.

4 Feb 2011

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

For blood cancer patients at high risk of relapse, hematopoietic stem cell transplantation (HSCT), the transplantation of blood-forming stem cells, is one of best options for treatment and a potential cure. Unfortunately, the most common complication of HSCT is graft-versus-host disease (GVHD), a serious and often deadly post-transplant complication that occurs when the newly transplanted donor cells recognize the recipient's own cells as foreign and react by attacking the cells in the patient's body.

4 Feb 2011

Roundup: N.Y., Texas, Calif. Medicaid plans spark protests; Conn. nursing homes; Fla. Medical Board

Gov. Andrew Cuomo's effort to strip lawmakers of power over the state's Medicaid program is facing a barrage of criticism in both houses and parties. Lawmakers on Wednesday described the governor's Medicaid proposal as an intrusion on their powers and said they would block it from becoming law.

4 Feb 2011

IDF commends Florida council for recommending SCID screening for all newborns

The Florida Genetics and Newborn Screening Program Advisory Council voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) – commonly known as bubble boy disease.

3 Feb 2011

PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies to kick off in Lund, Sweden

By learning more about these late effects of treatment, the health care services can, on the one hand, improve and reduce the intensity of the treatment, and, on the other hand, find appropriate ways to care for those suffering from side-effects of the treatment in adolescence and adulthood.

3 Feb 2011

Isotechnika closes licensing deal with ILJIN Life Science to advance development of voclosporin

Isotechnika Pharma Inc. is pleased to announce that it has finalized the Development, Distribution and License Agreement with ILJIN Life Science Co., Ltd., previously announced on November 16, 2010. Isotechnika will now receive the license fee of US$4.5 million plus proceeds of US$2.375 million from ILJIN's purchase of its first tranche of Common Shares from treasury.

3 Feb 2011

Damaged heart rebuilt with heart stem cells from children with congenital heart disease

A new study, revealing that heart stem cells from children with congenital heart disease were able to rebuild the damaged heart in the laboratory, could provide a new outlet for Emerging Healthcare Solutions' NASA bioreactor.

2 Feb 2011

First blood-based diagnostic test for LAM

Circadian Technologies has announced today that in conjunction with Cincinnati Children's Hospital Medical Center it has begun offering its LAM diagnostic, which is offered as a laboratory test compliant with CAP (College of American Pathologists) /CLIA regulations.

2 Feb 2011

Transplant News and Research

Enrollment suspended in WorldHeart's Levacor Ventricular Assist Device Bridge-To-Transplant Study

IDF commends Illinois advisory committee for unanimous vote to recommend SCID Newborn Screening

Rational use of heath care dollars for tonsillectomy

bcl3 gene limits lung injury during acute stress from illness, trauma, transplant

Gentium completes Defibrotide clinical studies, plans to file for regulatory approval

RemedyMD announces new ComprehensiveBMT to solve key HSCT research challenges

Study on non-surgical approach for treatment of liver hydatidosis

XDx and LabCorp enter non-hospital provider agreement for AlloMap molecular expression tests

Blood test for screening mad cow disease to come soon: Study

BCBSIL, IHA partner to reduce Illinois hospital readmissions through PREP initiative

Viewpoints: Judge Vinson's decision and Sarah Palin, Voting Rights Act; States' Medicaid 'burden;' Global fund controversy

Engineered cells take control of the cells and microenvironment following transplantation

Pediatric neurosurgery patient named Grand Marshal of 2011 Go the Distance fundraising event

Treg therapy ensures success of hematopoietic stem cell transplantation, without triggering GVHD

Roundup: N.Y., Texas, Calif. Medicaid plans spark protests; Conn. nursing homes; Fla. Medical Board

IDF commends Florida council for recommending SCID screening for all newborns

PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies to kick off in Lund, Sweden

Isotechnika closes licensing deal with ILJIN Life Science to advance development of voclosporin

Damaged heart rebuilt with heart stem cells from children with congenital heart disease

First blood-based diagnostic test for LAM

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News